 PHILADELPHIA, Jan. 04, 2022 GLOBE NEWSWIRE -- Context Therapeutics Inc. Context or the Company Nasdaq: CNTX, a womens oncology company developing small molecule and immunotherapy treatments for breast and gynecological cancers, today announced that Chief Executive Officer Martin Lehr will participate virtually in two investor conferences in January 2022. 